Skip to content
College News

Purdue Launches a Master’s Degree in Radiopharmaceutical Manufacturing

Published Updated 3 min read

(This article reports on news from July 2025.)

In July 2025 Purdue University announced a Master of Science in radiopharmaceutical manufacturing, which it described as the nation’s first graduate degree focused directly on manufacturing radiopharmaceuticals, the radioactive drugs used to diagnose and treat cancer and other diseases. The program was set to start in the spring 2026 semester in a hybrid format, with most courses online and an in-person capstone in a radiopharmaceutical manufacturing setting (Purdue News, July 8, 2025).

What Purdue announced

  • Industry partner: SpectronRx, an Indianapolis-based developer and manufacturer of radiopharmaceuticals, agreed to host a dedicated training facility at its northwest-side headquarters, near several other radiopharmaceutical manufacturers. Purdue said SpectronRx has more than 200,000 square feet of production space in Indiana, plus facilities in Danbury, Connecticut, and Europe, and supplies products to 29 countries. Its CEO, John Zehner, is a Purdue alumnus.
  • Who it is for: students from a range of disciplines and professionals already working in the field who need further training. Purdue noted it is also the sole provider of the continuing education that Board Certified Nuclear Pharmacists use to maintain their certification.
  • Career paths: Purdue listed pharmacy, chemistry, engineering, physics, radiation protection, health care, supply chain management and regulatory compliance.
  • Why Indiana: Eric Barker, Purdue’s vice president for health affairs and dean of the College of Pharmacy, said Purdue is “well positioned — both academically and geographically.” The life sciences group BioCrossroads promotes Indiana as the “Radiopharmaceutical Capital of the World,” a phrase registered as a trademark.

Radiopharmaceutical manufacturing in a university lab

Why radiopharmaceuticals need specialists

Radiopharmaceuticals contain radioactive isotopes that decay quickly, so they must be produced close to where they are used and delivered on tight schedules under both drug and radiation-safety regulations. Much of the recent growth comes from theranostics, which pairs a diagnostic imaging agent with a matching targeted radiation therapy. Purdue, citing BCC Research, said the theranostics market is expected to roughly triple from $4.3 billion to $12.7 billion by 2029, and Kara Weatherman, director of Purdue’s radiopharmaceutical programs, said this growth has “placed additional burden on an already limited workforce” (Purdue News, February 11, 2026). Purdue says it has the nation’s oldest and largest nuclear pharmacy program.

Program details

According to Purdue Online’s program page (Purdue Online):

  • Length and credits: 32 credit hours, about 24 months.
  • Required courses include nuclear physics and radiation protection in radiopharmaceutical manufacturing, radiation biology, good regulatory practices, quality management and audits, food and drug law and radioactive materials law for radiopharmaceuticals, an introduction to pharmaceutical manufacturing, and a capstone.
  • Two elective tracks: radiopharmaceutical product development (instrumentation, radionuclide production, radiopharmaceutical chemistry and analytical methods) or project management (smart manufacturing, pharmaceutical engineering, project finance, facility design and operations).
  • Capstone: usually completed at a radiopharmaceutical facility in Indianapolis or one closer to the student; an alternative project can be arranged if no facility is nearby.
  • Admission: a bachelor’s degree with at least a 3.0 GPA in chemistry, engineering, health physics, pharmacy (including PharmD) or a closely related field. No GRE is required, and prior manufacturing experience is helpful but not required.
  • Tuition: $1,150 per credit hour for both Indiana and non-Indiana residents, about $36,800 for 32 credits before fees.

What international students should know

  • This is an online program. F-1 students may count only one online class (or three credits) per term toward a full course of study (8 CFR 214.2(f)(6)(i)(G)), so an online master’s like this one cannot be the basis for an F-1 student visa. It suits international students who can study from abroad and arrange a capstone near them, or those already in the U.S. in another status that allows study.
  • Campus-based alternatives: students who want to study in the U.S. on an F-1 visa should look at Purdue’s residential graduate programs in pharmacy, medicinal chemistry, health physics or pharmaceutical engineering instead.
  • Check English and application requirements with Purdue Online’s enrollment counselors, as the program page does not list them.

Latest developments

In February 2026 Purdue described the degree as fully remote, with the option to complete in-person capstone projects and hands-on elective courses, and said the program ends with a capstone course with a radiopharmaceutical manufacturing company (Purdue News, February 11, 2026).

References

#Purdue University#online education#Master's Program

Comparing colleges?

Put up to six colleges side by side: rankings, admission rates, costs and graduation rates.

Compare colleges